NorthStar Healthcare Income, Inc.
OTC:NHHS
1.42 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 206.661 | 204.978 | 185.136 | 247.944 | 283.022 | 300.881 | 303.302 | 285.775 | 255.578 | 111.216 | 30.039 | 0.901 | 0 |
| Cost of Revenue
| 0.731 | 179.123 | 145.636 | 189.041 | 201.348 | 201.003 | 188.761 | 163.837 | 129.954 | 45.773 | 10.81 | 0.024 | 0 |
| Gross Profit
| 205.93 | 25.855 | 39.5 | 58.903 | 81.674 | 99.878 | 114.541 | 121.938 | 125.624 | 65.443 | 19.229 | 0.877 | 0 |
| Gross Profit Ratio
| 0.996 | 0.126 | 0.213 | 0.238 | 0.289 | 0.332 | 0.378 | 0.427 | 0.492 | 0.588 | 0.64 | 0.973 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 12.434 | 13.817 | 13.938 | 12.691 | 16.505 | 12.761 | 37.868 | 64.849 | 24.843 | 20.213 | 4.418 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.061 | 39.15 | 11.625 | 0 | 0 |
| SG&A
| 12.434 | 13.817 | 13.938 | 12.691 | 16.505 | 12.761 | 37.868 | 64.849 | 72.904 | 59.363 | 16.043 | 3.217 | 0 |
| Other Expenses
| 124.594 | 0 | 38.587 | 54.836 | 65.006 | 70.989 | 107.133 | 105.459 | 81.786 | 27.038 | 4.291 | 0.132 | 0 |
| Operating Expenses
| 137.028 | 14.5 | 52.525 | 67.527 | 81.511 | 83.75 | 145.001 | 170.308 | 154.69 | 86.401 | 20.334 | 3.349 | 0 |
| Operating Income
| 68.902 | 12.038 | 34.677 | 14.497 | -32.463 | 12.583 | -30.46 | -48.37 | -29.066 | -20.958 | -1.105 | -2.472 | 0 |
| Operating Income Ratio
| 0.333 | 0.059 | 0.187 | 0.058 | -0.115 | 0.042 | -0.1 | -0.169 | -0.114 | -0.188 | -0.037 | -2.744 | 0 |
| Total Other Income Expenses Net
| 77.207 | -172.213 | -41.415 | -35.141 | -264.348 | -93.803 | -121.446 | -77.792 | -69.289 | -51.141 | -15.264 | -0.23 | 0 |
| Income Before Tax
| 97.682 | -160.175 | -54.44 | 26.914 | -264.185 | -77.675 | -151.906 | -102.614 | -72.003 | -39.296 | -4.242 | -2.57 | 0 |
| Income Before Tax Ratio
| 0.473 | -0.781 | -0.294 | 0.109 | -0.933 | -0.258 | -0.501 | -0.359 | -0.282 | -0.353 | -0.141 | -2.852 | 0 |
| Income Tax Expense
| -0.082 | 0.074 | 0.061 | 0.099 | 0.053 | 0.075 | 0.114 | 0.043 | 7.104 | -5.598 | -1.39 | 0 | 0 |
| Net Income
| 97.993 | -156.885 | -54.501 | 25.067 | -264.238 | -77.75 | -151.578 | -137.771 | -141.275 | -82.37 | -14.945 | -2.56 | 0 |
| Net Income Ratio
| 0.474 | -0.765 | -0.294 | 0.101 | -0.934 | -0.258 | -0.5 | -0.482 | -0.553 | -0.741 | -0.498 | -2.841 | 0 |
| EPS
| 0.53 | -0.83 | -0.28 | 0.13 | -1.39 | -0.41 | -0.81 | -0.74 | -0.77 | -0.63 | -0.38 | -1.26 | 0 |
| EPS Diluted
| 0.53 | -0.83 | -0.28 | 0.13 | -1.39 | -0.41 | -0.81 | -0.74 | -0.77 | -0.63 | -0.38 | -1.26 | 0 |
| EBITDA
| 184.723 | -68.42 | 27.425 | 69.333 | -130.514 | 62.21 | -2.04 | 7.937 | -2.714 | -37.201 | -8.941 | -2.34 | 0 |
| EBITDA Ratio
| 0.894 | -0.334 | 0.148 | 0.28 | -0.461 | 0.207 | -0.007 | 0.028 | -0.011 | -0.334 | -0.298 | -2.597 | 0 |